Back to Results
First PageMeta Content
Property law / Inventive step and non-obviousness / KSR v. Teleflex / Person having ordinary skill in the art / Utility / Patent prosecution / Patentability / Prior art / Patent examiner / Patent law / Law / Civil law


Article_Nichols-Carroll_LCA_At_USPTO_CAFC_08182014_FINAL
Add to Reading List

Document Date: 2014-12-15 10:46:39

Open Document

File Size: 1,08 MB

Share Result on Facebook

Company

Zenith Goldline Pharmaceuticals Inc. / Merck & Co. / Otsuka Pharm / Eisai Co. Ltd. / Inds PLC / Bristol-Myers Squibb Co. / Takeda / USA Inc. / Danbury Pharmacal Inc. / Sandoz Inc. / Biocraft Labs. / Teleflex / Ranbaxy Labs. / Patent Appeals / Alphapharm Pty. Ltd. / Teva Pharma / Daiichi Sankyo Co. Ltd. / Vertex / Altana Pharma AG / Id. 7 Yamanouchi Pharmaceutical / Abbott Laboratories / Eli Lilly & Co. / Matrix Labs. / /

Country

United States / /

Currency

VND / /

/

Event

FDA Phase / /

IndustryTerm

chemical obviousness battle / pharmaceutical compound patents / chemical claims / chemical compounds / prior art search / chemical obviousness analysis / case law / chemical inventions / chemical obviousness / pharmaceutical drug molecules / patent portfolio management / chemical obviousness law / /

Organization

Patent and Trademark Office / U.S. Department of Commerce / LEAD COMPOUND ANALYSIS In Patent Office / Appeal Board / Patent Office / Patent Trial and Appeal Board / US Federal Reserve / Board of Patent Appeals and Interferences / /

Person

Grant Review / Deacon / Jeffry M. Nichols / Brinks Gilson / Reddy / William A. Carroll / /

Position

intellectual property attorney / attorney / General / Player / parte Cao / C.C.P.A. / Cao / chemist / /

Product

glucagon / risperidone / cimetidine / omeprazole / clozapine / glycine / lead / /

Technology

Biotechnology / /

SocialTag